You searched for point-of-care | Page 69 of 259

Nanopath Secures $10M to Develop POC Diagnostics for Women’s Health

Nanopath will develop & commercialize a biosensing platform that aims to transform how women’s pelvic & gynecologic infections are diagnosed.

Posted by Andy Lundin | Aug 16, 2022 | Covid 19, Rapid Assays |

Researchers have created an easy-to-use diagnostic test for COVID infection that is more sensitive than commonly used at-home antigen tests.

The July 2022 Tech Guide that appears in Clinical Lab Products (CLP) features a wide-range of products from top laboratory providers.

These biosensors can be used to screen certain diseases, as well as to monitor environments for specific chemical compounds in the air.

A new POC diagnostic device can simultaneously detect the presence of both SARS-CoV-2 RNA & antibodies against the virus in saliva.